MERLIN: Two-Year Results of Brolucizumab in Participants with Neovascular Age-Related Macular Degeneration and Persistent Retinal Fluid. - Brown DM; Jaffe GJ; Wykoff CC; Adiguzel E; Heier JS; Khanani AM (Ophthalmology, 2025)